165 related articles for article (PubMed ID: 12878984)
21. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
22. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
[TBL] [Abstract][Full Text] [Related]
23. High serum concentration of total inhibin in polycystic ovary syndrome.
Tsigkou A; Luisi S; De Leo V; Patton L; Gambineri A; Reis FM; Pasquali R; Petraglia F
Fertil Steril; 2008 Nov; 90(5):1859-63. PubMed ID: 18423626
[TBL] [Abstract][Full Text] [Related]
24. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
25. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
26. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?
Wijeyaratne CN; Nirantharakumar K; Balen AH; Barth JH; Sheriff R; Belchetz PE
Clin Endocrinol (Oxf); 2004 May; 60(5):560-7. PubMed ID: 15104558
[TBL] [Abstract][Full Text] [Related]
27. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
Oral B; Mermi B; Dilek M; Alanoğlu G; Sütçü R
Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
[TBL] [Abstract][Full Text] [Related]
28. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.
Moran LJ; Hutchison SK; Meyer C; Zoungas S; Teede HJ
Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710
[TBL] [Abstract][Full Text] [Related]
29. Procoagulants and osteonecrosis.
Jones LC; Mont MA; Le TB; Petri M; Hungerford DS; Wang P; Glueck CJ
J Rheumatol; 2003 Apr; 30(4):783-91. PubMed ID: 12672200
[TBL] [Abstract][Full Text] [Related]
30. Comparison of ovarian stromal blood flow between fertile women with normal ovaries and infertile women with polycystic ovary syndrome.
Ng EH; Chan CC; Yeung WS; Ho PC
Hum Reprod; 2005 Jul; 20(7):1881-6. PubMed ID: 15845598
[TBL] [Abstract][Full Text] [Related]
31. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
[TBL] [Abstract][Full Text] [Related]
32. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.
Vgontzas AN; Trakada G; Bixler EO; Lin HM; Pejovic S; Zoumakis E; Chrousos GP; Legro RS
Metabolism; 2006 Aug; 55(8):1076-82. PubMed ID: 16839844
[TBL] [Abstract][Full Text] [Related]
33. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
34. MTHFR C 677T mutation and 4G/5G PAI-1 polymorphism in patient with polycystic ovarian syndrome.
Radaković B; Goldstajn MS
Coll Antropol; 2007 Sep; 31(3):919-21. PubMed ID: 18041407
[TBL] [Abstract][Full Text] [Related]
35. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
36. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
37. Thrombophilia and unexplained pregnancy loss in Indian patients.
Vora S; Shetty S; Salvi V; Satoskar P; Ghosh K
Natl Med J India; 2008; 21(3):116-9. PubMed ID: 19004141
[TBL] [Abstract][Full Text] [Related]
38. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis.
Coulam CB; Wallis D; Weinstein J; DasGupta DS; Jeyendran RS
Am J Reprod Immunol; 2008 Nov; 60(5):426-31. PubMed ID: 18803625
[TBL] [Abstract][Full Text] [Related]
39. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G
Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
[TBL] [Abstract][Full Text] [Related]
40. Pregnancy outcomes after laparoscopic ovarian drilling in women with polycystic ovarian syndrome.
Al-Ojaimi EH
Saudi Med J; 2006 Apr; 27(4):519-25. PubMed ID: 16598331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]